Outcomes For MCL Patients and Impact of Relapse Timing After Transplant on OS
August 22nd 2021Peter Riedell, MD, an assistant professor of medicine at University of Chicago Medicine, discusses outcomes for mantle cell lymphoma patients and the impact of the timing of relapse on overall survival after autologous stem cell transplantation.
Watch
Role of Precision Medicine in PSMA-Positive mCRPC
August 20th 2021Evan Y. Yu, MD, shares insight on the rationale for precision medicine in patients with progressive PSMA-positive metastatic castration resistant prostate cancer (mCRPC) who have been previously treated with androgen axis inhibitor drugs and taxane.
Watch
How Prior Chemotherapy Impacts ICI Survival Outcomes in Patients With Lung Cancer
August 19th 2021Jorge Nieva, MD, discusses the results of the Impower010 study, which evaluated the efficacy of the checkpoint inhibitor atezolizumab after chemotherapy for lung cancer compared to best supportive care.
Watch
Determining the Efficacy of Neoadjuvant Cemiplimab in Hepatocellular Carcinoma
August 18th 2021Thomas Marron, MD, PhD an assistant professor of hematology and medical oncology at Mount Sinai Hospital, discusses the study design and key goals of adding perioperative cemiplimab, an anti-PD-1 antibody, to surgical resection for hepatocellular carcinoma.
Watch
Somatic Gene Alterations Correlate With Resistance in Black Patients With Luminal Breast Tumors
August 17th 2021Yael Simons, MD, discusses the study of somatic driver gene alterations in a consecutive series of luminal breast tumors in Black patients, which received an American Society of Clinical Oncology Merit Award.
Watch
Westin Explains the Need for Novel Therapies in the Endometrial Cancer Space
August 14th 2021Shannon Westin, MD, MPH, FACOG, a gynecologic oncologist at The University of Texas MD Anderson Cancer Center, discusses the use of durvalumab with or without olaparib for the treatment of endometrial cancers.
Watch